Results 151 to 160 of about 8,788 (204)

Rapid establishment of public sector COVID-19 test-and-treatment programmes across seven low- and middle-income countries: implementation strategies and program monitoring results. [PDF]

BMJ Glob Health
Boeke CE, Hamza N, Agwuocha C, Amako O, Detleuxay K, Gao M, Griffith BC, Gumulira Y, Urli Hodges E, Joseph J, Lufesi N, Macharia E, Mbewe N, McCarthy E, Mintah FO, Mukiibi M, Mulenga M, Ngwije A, Ofori-Boadu L, Okoli IU, Phongphila S, Ramers C, Regan S, Twinomujuni E, Rwagasore E, Tebor J, Udayakumar K, COVID-19 Treatment QuickStart Consortium.   +27 more
europepmc   +1 more source

An intrinsic loop-mediated structural stability modulating inhibitor potency in the SADS-CoV and SARS-CoV-2 main proteases. [PDF]

PLoS Pathog
Zeng R, Cui S, Xia X, Huang C, Sun J, Deng X, Gui Q, Fan H, Liu X, Yu Y, Yang S, Lei J.   +11 more
europepmc   +1 more source

Combination Treatment of Persistent SARS-CoV-2 Infection with Dual Antiviral Therapy and Intravenous Immunoglobulin: A Novel Approach. [PDF]

J Clin Med
Blizou M, Lampadakis S, Karofylakis E, Blizou A, Thomas K, Prountzos S, Papavasileiou V, Raptakis T, Manali ED, Papiris SA, Loukides S, Antonogiannaki EM.   +11 more
europepmc   +1 more source

Omicron Subvariants Infection Kinetics and Nirmatrelvir Efficacy in Transgenic K18-hACE2 Mice. [PDF]

Int J Mol Sci
Sharma V, Dolgov E, Tillery T, Mendez Romero C, Rojas-Triana A, Villalba Guzman DM, Goldgirsh K, Rasheed R, Gonzalez-Jimenez I, Alvarez N, Park S, Murugan M, Nelson AM, Perlin DS.   +13 more
europepmc   +1 more source

Tackling emerging viral diseases with epidemic potential [PDF]

Li, Pengfei
core  

Some of the next articles are maybe not open access.

Related searches:

Nirmatrelvir+ritonavir

Reactions Weekly, 2023
  +7 more sources